1. Home
  2. ARES vs KVUE Comparison

ARES vs KVUE Comparison

Compare ARES & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • KVUE
  • Stock Information
  • Founded
  • ARES 1997
  • KVUE 2022
  • Country
  • ARES United States
  • KVUE United States
  • Employees
  • ARES N/A
  • KVUE N/A
  • Industry
  • ARES Investment Managers
  • KVUE Specialty Chemicals
  • Sector
  • ARES Finance
  • KVUE Consumer Discretionary
  • Exchange
  • ARES Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • ARES 38.7B
  • KVUE 39.9B
  • IPO Year
  • ARES 2014
  • KVUE 2023
  • Fundamental
  • Price
  • ARES $183.46
  • KVUE $19.11
  • Analyst Decision
  • ARES Buy
  • KVUE Buy
  • Analyst Count
  • ARES 15
  • KVUE 12
  • Target Price
  • ARES $185.29
  • KVUE $24.21
  • AVG Volume (30 Days)
  • ARES 1.4M
  • KVUE 23.5M
  • Earning Date
  • ARES 10-31-2025
  • KVUE 11-06-2025
  • Dividend Yield
  • ARES 2.42%
  • KVUE 4.35%
  • EPS Growth
  • ARES N/A
  • KVUE 28.77
  • EPS
  • ARES 1.76
  • KVUE 0.74
  • Revenue
  • ARES $4,827,669,000.00
  • KVUE $15,141,000,000.00
  • Revenue This Year
  • ARES $19.11
  • KVUE $0.09
  • Revenue Next Year
  • ARES $18.26
  • KVUE $3.19
  • P/E Ratio
  • ARES $105.15
  • KVUE $25.47
  • Revenue Growth
  • ARES 49.87
  • KVUE N/A
  • 52 Week Low
  • ARES $110.63
  • KVUE $17.15
  • 52 Week High
  • ARES $200.49
  • KVUE $25.17
  • Technical
  • Relative Strength Index (RSI)
  • ARES 54.46
  • KVUE 37.88
  • Support Level
  • ARES $173.36
  • KVUE $18.05
  • Resistance Level
  • ARES $181.86
  • KVUE $18.97
  • Average True Range (ATR)
  • ARES 3.98
  • KVUE 0.73
  • MACD
  • ARES 0.37
  • KVUE -0.16
  • Stochastic Oscillator
  • ARES 82.10
  • KVUE 45.48

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: